Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients.
We compared medical resource use and costs among rheumatoid arthritis (RA) patients receiving alternative disease-modifying antirheumatic drugs (DMARDs). The cohort study used data from a managed care organization. Health plan members who were prescribed DMARD therapy for at least 2 consecutive mont...
Main Authors: | Griffiths, R, Bar-Din, M, MacLean, C, Sullivan, E, Herbert, R, Yelin, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.
by: Griffiths, R, et al.
Published: (2000) -
Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
by: Emery, P, et al.
Published: (1994) -
Disease-Modifying Antirheumatic Diets: The New Treatment Modalities for Rheumatoid Arthritis
by: Shweta Khanna, et al.
Published: (2018-07-01) -
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01) -
Lung lesion caused by the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yuriy Vladimirovich Murav'ev, et al.
Published: (2010-12-01)